Rite Aid

Rite Aid's White-Coat Problem: That's Not a Pharmacist

When you step up to the pharmacy counter at Rite Aid to discuss your symptoms with the helpful employee clad in a white coat, do you know if you're speaking to a pharmacist or just a "wellness ambassador"? Two U.S. senators say that the distinction isn't clear enough. Here's why they have a problem.

Retailers Push Back Against Extreme Couponing Trend

Memo to extreme couponers: Some retailers, particularly supermarkets and drugstore chains, are mad as hell and they're not going to take it anymore. To save their bottom lines, they're setting limits on just how much all your coupon cleverness can save you.

5 Companies That Are Still Losing Money

The economy may be ugly for workers, but most companies are making money. In fact, many Wall Street darlings are checking in with record profits. Then again, most doesn't mean all. Here are five notable companies that are losing money this year -- and possibly beyond.

Drugstore Markups Are Worse Than You'd Imagine

It's happened to all of us. You head into the drugstore to grab some aspirin or toothpaste and you walk out carrying a bag stuffed with impulse items -- even groceries. Those impulse buys will cost you -- a lot: A new report from finds drugstore prices average more than 36% higher than supermarket prices.

Days and Dollars Lost to the Flu Hit a Fever Pitch

Tallying up the flu's effect on our economy is enough to make you sick. Influenza was responsible for 100 million lost work days in 2010, according to a Walgreens study. That's $7 billion in lost wages, and $10 billion in lost productivity. Inspired to get vaccinated this year? We'll point you to the best deal.

Walgreen Buys Drugstore.com for Twice Its Value

After years of trying to expand its online presence through organic growth, giant drug store chain Walgreen has decided to buy a bigger Web footprint, acquiring drugstore.com, the country's eighth-largest e-tailer -- and it's paying a premium price.

Face-Off on Stocks: Walgreen, CVS, Rite Aid


Not everyone is happy about the mild start to the cold-and-flu season. The nation's drugstore chains, already under pricing pressure from Walmart and each other, would be happier if the rest of us had coughs and sniffles. Here are bull and bear cases for the three big chains. [Video]

The 10 Retailers That'll Have a Not-So-Jolly Holiday

Holiday sales are historically make-or-break for many retailers, and every year, several break -- and even go out of business. Others make large cuts in their store numbers and employees. 24/7 Wall St. combed through the numbers and spotlights 10 retailers that won't look the same next year -- if they're even around.

Rite Aid Reports Narrower Loss and Lower Revenue

Rite Aid posted Wednesday morning a narrower loss of $73.7 million, or 9 cents per share in its fiscal first quarter, compared to last year's first quarter net loss of $98.4 million, or 11 cents per share. The narrower loss was the result of a decrease in selling, general and administrative expense and lower charges related to store closings contributed to the decrease in net loss. Analysts had expected a loss of 14 cents per share.

Rite Aid's Headaches Mean 'Investors Beware'

If you're a high-roller looking for a little action, Rite Aid's sell-off could be a buying opportunity. But sober types best stay away. The No. 3 drugstore chain is bleeding red ink, its balance sheet is a mess, sales are falling and it's closing stores.